Cargando…
Current Overview on Hypercoagulability in COVID-19
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought many unique pathologies, such as coagulopathy, prompting a desperate need for effective management. COVID-19-associated coagulopathy (CAC) can cause various thromboem...
Autores principales: | Singhania, Namrata, Bansal, Saurabh, Nimmatoori, Divya P., Ejaz, Abutaleb A., McCullough, Peter A., Singhania, Girish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398761/ https://www.ncbi.nlm.nih.gov/pubmed/32748336 http://dx.doi.org/10.1007/s40256-020-00431-z |
Ejemplares similares
-
Role of renin–angiotensin–aldosterone system inhibitors in heart failure and chronic kidney disease
por: Singhania, Namrata, et al.
Publicado: (2020) -
Severe nonbacterial preseptal cellulitis from adenovirus detected via pooled meta‐genomic testing
por: Bansal, Saurabh, et al.
Publicado: (2020) -
An Atypical Presentation of Novel Coronavirus Disease 2019 (COVID-19)
por: Singhania, Namrata, et al.
Publicado: (2020) -
If You Go Up, You May Fall: A Rare Case of Rapidly Progressing Multifocal High-Altitude Vascular Thrombosis
por: Nimmatoori, Divya Pramod, et al.
Publicado: (2020) -
Recurrent arteriovenous graft thrombosis in COVID‐19 positive patient
por: Singh, Anil Kumar, et al.
Publicado: (2021)